What topics does this cannabis study cover?

This study covers research on: THC.

Where was this research published?

Published in The International journal on drug policy on June 26, 2026.

How banning synthetic cannabinoids backfires with dangerous new drugs

Q: What did this research study find?

This study examined **687 drug samples from 317 police cases in Dubai between 2011 and 2022** to track how legislation affects the availability of *synthetic cannabinoid receptor agonists* (SCRA) – dangerous synthetic compounds designed to mimic cannabis effects. Researchers identified **64 distinct

The impacts of proactive scheduling of synthetic cannabinoid receptor agonists on police drug detections in Dubai, United Arab Emirates (2011 - 2022).

The International journal on drug policy • June 26, 2026 • Moderately Relevant

🤖

AI Summary

This study examined 687 drug samples from 317 police cases in Dubai between 2011 and 2022 to track how legislation affects the availability of synthetic cannabinoid receptor agonists (SCRA) – dangerous synthetic compounds designed to mimic cannabis effects. Researchers identified 64 distinct SCRA compounds using advanced chemical analysis. Importantly, these synthetic substances are far more potent than natural cannabis and carry severe health risks including addiction, dangerous behavioral changes, overdose, and long-term neurological damage. The research reveals a troubling market dynamic: as authorities banned individual SCRA compounds, they disappeared from Dubai's streets, but were rapidly replaced by new synthetic alternatives.

The study documents a striking pattern of evolving compound dominance over the decade, with different SCRA becoming prevalent at different times – from JWH-019 in 2011 to increasingly complex variants like MDMB-4en-PINACA by 2022. This shifting landscape suggests that clandestine chemists are continuously developing new formulations to circumvent regulations. While the data shows that legislative scheduling does successfully remove specific SCRA from the market, it also demonstrates a problematic "cat and mouse" dynamic where prohibition triggers innovation rather than elimination of the drug problem.

The findings underscore a critical challenge for public health and law enforcement: reactive scheduling of individual compounds is insufficient to combat the SCRA threat. The rapid emergence of new alternatives suggests that broader, more adaptive regulatory strategies – potentially including class-based legislation that targets entire chemical families rather than individual molecules – may be necessary. For cannabis users and policymakers alike, this research highlights why synthetic cannabinoids remain a significant public health concern despite their structural similarity to natural cannabis, and why the illicit drug market's adaptability requires equally flexible enforcement responses.

📄 Original Abstract

Over the past decade, the global use of synthetic cannabinoid receptor agonists (SCRA) has surged, driven by factors such as affordability, ease of synthesis, and discreet online distribution. These substances are designed to imitate the effects of cannabis; however, they belong to entirely different classes of synthetic compounds, are much more potent and are linked to severe health consequences, including psychological addiction, acute behavioral issues, fatal and non-fatal overdose, and long-term neurological damage. Their wide availability, strong potency, and ability to avoid detection classify them as high-risk drugs. This research focuses on demonstrating the impacts of proactive scheduling of SCRA on trends in police seizures of these substances in Dubai, United Arab Emirates (UAE), between 2011 and 2022. 687 samples from 317 cases were analyzed by GC-MS, and 64 distinct SCRA were detected. Most SCRA were found to be added to herbal materials or in paper or liquid forms. There was a steady increase in SCRA police seizures over time, mirroring global trends. The most commonly detected SCRA evolved over the study period, with JWH-019 predominating in 2011, followed by AM-2201 (2012-2013), AKB48 (2014), AB-CHMINACA (2015), 5-fluoro AKB48 analogues (2016-2018), 5F-MDMB-PICA (2019), 5-fluoro MDMB-PINACA (2020), and MDMB-4en-PINACA by the end of the study period (2021-2022). The impact of legislation on the presence of SCRA in Dubai's drug market was illustrated using a heat map that showed how SCRA that are added to the drug schedules promptly disappear from the market, but are rapidly replaced by new SCRA. In conclusion, the increasingly rapid development of the SCRA drug market needs to be continually monitored. While legislative action, such as that implemented in the UAE, appears to inhibit the availability of specific SCRA, the data suggest a 'cat and mouse' dynamic whereby the prohibition of individual compounds is followed by the emergence of new, lesser-known SCRA, highlighting the need for broader and more adaptive regulatory strategies.

Paper Type

📄 Research

Publication

Journal: The International journal on drug policy
Published: June 26, 2026
PMID: 42361558
DOI: 10.1016/j.drugpo.2026.105410

Authors (8)

Auhood Y Al Ali Dubai police, General Department of Forensic Science and Criminology, Forensic Chemistry Section, United Arab Emirates. Electronic address: Aybelhiool@gmail.com.
Hessa A Ahli Dubai police, General Department of Forensic Science and Criminology, Forensic Chemistry Section, United Arab Emirates. Electronic address: H.eahli@dubaipolice.gov.ae.
Salama B Almheiri Dubai police, General Department of Forensic Science and Criminology, Forensic Chemistry Section, United Arab Emirates. Electronic address: Sbalmheiri@dubaipolice.gov.ae.
Fatma M Almadani Dubai police, General Department of Forensic Science and Criminology, Forensic Chemistry Section, United Arab Emirates. Electronic address: F.almadani@dubaipolice.gov.ae.
Eman S Almazrouei Dubai police, General Department of Forensic Science and Criminology, Forensic Chemistry Section, United Arab Emirates. Electronic address: e.almazroei@hotmail.com.
+3 more authors